Oxford Immunotec Global (NASDAQ:OXFD) has appointed Karen Koski as head of strategy and investor relations, a newly created position that will report directly to CEO, Peter Wrighton-Smith. The appointment is effective on June 21.Read More
RepliCel Life Sciences (OTCQB:REPCF; TSX-V:RP; FRA:P6P2) has signed agreements with two European firms to get the company's commercial-grade RCI-02 dermal injector prototypes manufactured and tested.Read More
JMP Securities resumed coverage of Cardiovascular Systems (NASDAQ:CSII) with a “market outperform” rating and $35 price target. The stock closed at $24.11 on Thursday.
Cardiovascular is a medical technology company with a novel platform for eliminating vessel calcification, strong reimbursement, solid clinical evidence, and large, untapped markets.Read More